Latest Partnerships News

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Catalyst Metals has received regulatory approval to build an exploration tunnel at its Four Eagles gold project in Victoria, marking a pivotal step toward underground access and resource expansion. The company is advancing its high-grade gold resource with a secured processing facility and plans for further drilling in FY26.

Odyssey Gold Limited has reported encouraging results from a technical study supporting open pit mining at its Tuckanarra Gold Project and signed a key Memorandum of Understanding to process ore at Monument Mining’s nearby Burnakura plant.

Ionic Rare Earths has raised $15.6 million through a heavily oversubscribed rights issue and placement, anchored by a $3 million strategic investment from U.S.-based Argentem Creek Partners. The capital will fund the company’s global expansion in magnet recycling and rare earth supply chain development amid rising geopolitical tensions.

Critical Resources Limited has promoted Tim Wither from CEO to Managing Director, rewarding his leadership with a substantial incentive package as the company advances its critical minerals portfolio.

Auric Mining has begun processing high-grade ore from its Munda Starter Pit earlier than planned, with first gold sales expected this month and cash flow anticipated by November.

Tungsten Mining NL (ASX, TGN) reinforces its position as a leading tungsten resource holder outside China, unveiling a robust development strategy aligned with soaring global demand and supply constraints.

Tungsten Mining NL is moving to list on the U.S. OTCQB Market, aiming to tap into strong North American investor interest as tungsten prices climb and critical mineral security becomes a priority.

Canterbury Resources is on the cusp of completing a pivotal scoping study for its Briggs Copper Project, while deep drilling advances to unlock higher-grade mineralisation. The company also moves forward with new exploration initiatives and a share purchase plan to bolster funding.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.